- Home
- Publications
- Publication Search
- Publication Details
Title
A novel GABAergic dysfunction in human Dravet syndrome
Authors
Keywords
-
Journal
EPILEPSIA
Volume 59, Issue 11, Pages 2106-2117
Publisher
Wiley
Online
2018-10-11
DOI
10.1111/epi.14574
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment Strategies for Dravet Syndrome
- (2018) Kelly G. Knupp et al. CNS DRUGS
- Modulation of GABAA Receptors in the Treatment of Epilepsy
- (2018) Eleonora Palma et al. CURRENT PHARMACEUTICAL DESIGN
- KCC2, epileptiform synchronization, and epileptic disorders
- (2018) Graziella Di Cristo et al. PROGRESS IN NEUROBIOLOGY
- Overexpressing wild-type γ2 subunits rescued the seizure phenotype in Gabrg2 +/Q390X Dravet syndrome mice
- (2017) Xuan Huang et al. EPILEPSIA
- Dravet syndrome and its mimics: Beyond SCN1A
- (2017) Dora Steel et al. EPILEPSIA
- Impaired intracortical inhibition demonstrated in vivo in people with Dravet syndrome
- (2017) William M. Stern et al. NEUROLOGY
- Mutations in GABRB3
- (2017) Rikke S. Møller et al. NEUROLOGY
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABA A receptors
- (2017) T. Bakas et al. PHARMACOLOGICAL RESEARCH
- Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome
- (2017) Joshua S. Kaplan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex
- (2016) Evan J. Hess et al. EPILEPSIA
- Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions
- (2016) Gabriele Ruffolo et al. NEUROBIOLOGY OF DISEASE
- Jointly reduced inhibition and excitation underlies circuit-wide changes in cortical processing in Rett syndrome
- (2016) Abhishek Banerjee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A deleterious Nav1.1 mutation selectively impairs telencephalic inhibitory neurons derived from Dravet Syndrome patients
- (2016) Yishan Sun et al. eLife
- Neurological and neuropsychiatric aspects of tuberous sclerosis complex
- (2015) Paolo Curatolo et al. LANCET NEUROLOGY
- Tonic GABAA Receptors as Potential Target for the Treatment of Temporal Lobe Epilepsy
- (2015) S. Schipper et al. MOLECULAR NEUROBIOLOGY
- Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome
- (2015) Gabriele Deidda et al. NATURE MEDICINE
- The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders
- (2015) Sien Braat et al. NEURON
- Incidence of Dravet Syndrome in a US Population
- (2015) Y. W. Wu et al. PEDIATRICS
- Basic Mechanisms of Epileptogenesis in Pediatric Cortical Dysplasia
- (2014) Sara Abdijadid et al. CNS Neuroscience & Therapeutics
- Effect of spontaneous seizures on GABAAreceptor α4 subunit expression in an animal model of temporal lobe epilepsy
- (2014) Heidi L Grabenstatter et al. EPILEPSIA
- Cation-chloride cotransporters in neuronal development, plasticity and disease
- (2014) Kai Kaila et al. NATURE REVIEWS NEUROSCIENCE
- Untangling the Dravet Syndrome Seizure Network: The Changing Face of a Rare Genetic Epilepsy
- (2014) Ravi Chopra et al. Epilepsy Currents
- Stiripentol exhibits higher anticonvulsant properties in the immature than in the mature rat brain
- (2013) Stéphane Auvin et al. EPILEPSIA
- Fractalkine/CX3CL1 modulates GABAAcurrents in human temporal lobe epilepsy
- (2013) Cristina Roseti et al. EPILEPSIA
- A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABAAreceptors
- (2012) ML Jensen et al. BRITISH JOURNAL OF PHARMACOLOGY
- Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia
- (2011) Delia M. Talos et al. ANNALS OF NEUROLOGY
- Anomalous levels of Cl− transporters cause a decrease of GABAergic inhibition in human peritumoral epileptic cortex
- (2011) Luca Conti et al. EPILEPSIA
- KCC2 was downregulated in small neurons localized in epileptogenic human focal cortical dysplasia
- (2011) Chigusa Shimizu-Okabe et al. EPILEPSY RESEARCH
- Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
- (2011) Uwe Rudolph et al. NATURE REVIEWS DRUG DISCOVERY
- Comparative study of cellular and synaptic abnormalities in brain tissue samples from pediatric tuberous sclerosis complex and cortical dysplasia type II
- (2010) Carlos Cepeda et al. EPILEPSIA
- Progressive NKCC1-Dependent Neuronal Chloride Accumulation during Neonatal Seizures
- (2010) V. I. Dzhala et al. JOURNAL OF NEUROSCIENCE
- Epileptogenesis in the immature brain: emerging mechanisms
- (2009) Sanjay N. Rakhade et al. Nature Reviews Neurology
- Microtransplantation of ligand-gated receptor-channels from fresh or frozen nervous tissue into Xenopus oocytes: A potent tool for expanding functional information
- (2009) F. Eusebi et al. PROGRESS IN NEUROBIOLOGY
- GABAA Receptors in Normal Development and Seizures: Friends or Foes?
- (2008) Aristea Galanopoulou Current Neuropharmacology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started